CompletedPhase 1NCT04702178

A Clinical Trial of COVAC-2 in Healthy Adults

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Saskatchewan
Principal Investigator
Joanne M Langley, MD
Canadian Center for Vaccinology
Intervention
COVAC-2(biological)
Enrollment
61 target
Eligibility
18 years · All sexes
Timeline
20212022

Study locations (2)

Collaborators

Government of Canada · Government of Saskatchewan · Vaccine Formulation Institute (VFI) · Seppic

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04702178 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials